After adjustment for clinical risk predictors , left ventricular ejection fraction , markers of renal function , and established cardiovascular biomarkers , FGF-@ concentration was independently associated with an increased risk of cardiovascular death or heart failure among patients allocated to placebo ( quartile @ hazard ratio : @ ; @ % confidence interval , @ to @ ; p = @ ) and significantly improved metrics of discrimination .